Literature DB >> 6088678

Identification of a herpes simplex virus type 1 polypeptide which is a component of the virus-induced ribonucleotide reductase.

V G Preston, J W Palfreyman, B M Dutia.   

Abstract

We have characterized a temperature-sensitive mutant of herpes simplex virus type 1 (HSV-1), 17tsVP1207, that induces a thermolabile ribonucleotide reductase activity. This mutant was derived from the multiple mutant tsG. Fine-structure mapping studies showed that the defect in 17tsVP1207 lies within an 800 bp sequence between genome map coordinates 0.580 and 0.585 in the gene encoding a polypeptide of 140 000 mol. wt. (Vmw136, ICP6). Since the mutation in this polypeptide produced a temperature-sensitive ribonucleotide reductase activity, Vmw136 must be a component of the herpes simplex virus-induced ribonucleotide reductase. The mRNA of Vmw136 has a common 3' terminus with an mRNA encoding a 38 000 mol. wt. polypeptide (Vmw38). Although the polypeptide-coding sequences of these mRNAs do not overlap, monoclonal antibodies against Vmw136 immunoprecipitated Vmw38 as well as Vmw136 from wild-type HSV-1-infected cells. Our data do not exclude the possibility that Vmw38 is part of the ribonucleotide reductase complex but suggest that this species on its own is not responsible for the HSV-induced enzyme activity.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6088678     DOI: 10.1099/0022-1317-65-9-1457

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  39 in total

1.  Herpes simplex virus ribonucleotide reductase mutants are hypersensitive to acyclovir.

Authors:  D M Coen; D J Goldstein; S K Weller
Journal:  Antimicrob Agents Chemother       Date:  1989-08       Impact factor: 5.191

2.  Herpes simplex virus IE63 acts at the posttranscriptional level to stimulate viral mRNA 3' processing.

Authors:  J McLauchlan; A Phelan; C Loney; R M Sandri-Goldin; J B Clements
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

3.  Identification of herpes simplex virus type 1 genes required for origin-dependent DNA synthesis.

Authors:  C A Wu; N J Nelson; D J McGeoch; M D Challberg
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

4.  Suppression of extracellular signal-regulated kinase activity in herpes simplex virus 1-infected cells by the Us3 protein kinase.

Authors:  Uyanga Chuluunbaatar; Richard Roller; Ian Mohr
Journal:  J Virol       Date:  2012-05-16       Impact factor: 5.103

5.  Herpes simplex virus specifies two subunits of ribonucleotide reductase encoded by 3'-coterminal transcripts.

Authors:  M A Swain; D A Galloway
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

6.  Neutralization of herpes simplex virus ribonucleotide reductase activity by an oligopeptide-induced antiserum directed against subunit H2.

Authors:  E A Cohen; P Gaudreau; P Brazeau; Y Langelier
Journal:  J Virol       Date:  1986-12       Impact factor: 5.103

7.  Identification of immediate-early-type cis-response elements in the promoter for the ribonucleotide reductase large subunit from herpes simplex virus type 2.

Authors:  J P Wymer; T D Chung; Y N Chang; G S Hayward; L Aurelian
Journal:  J Virol       Date:  1989-06       Impact factor: 5.103

8.  Structures of herpes simplex virus type 1 genes required for replication of virus DNA.

Authors:  D J McGeoch; M A Dalrymple; A Dolan; D McNab; L J Perry; P Taylor; M D Challberg
Journal:  J Virol       Date:  1988-02       Impact factor: 5.103

9.  Isolation and characterization of herpes simplex virus type 1 host range mutants defective in viral DNA synthesis.

Authors:  E P Carmichael; M J Kosovsky; S K Weller
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

10.  Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 lacZ insertion mutant.

Authors:  D J Goldstein; S K Weller
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.